Jupiter Neurosciences (JUNS) Change in Cash (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Change in Cash of $3.1 million for Q4 2025, down 18.67% year-over-year from $3.8 million in Q4 2024, and up 365.54% quarter-over-quarter from -$1.2 million in Q3 2025.
Jupiter Neurosciences (JUNS) Change in Cash (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Change in Cash for 3 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash fell 18.67% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $19832.0 (down 99.47% YoY), while the FY2025 annual figure was $19832.0, down 99.47% from the prior year.
- Change in Cash climbed to $3.1 million in Q4 2025 per JUNS's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $3.8 million in Q4 2024 and bottomed at -$1.2 million in Q3 2025.
- Historically, Change in Cash has averaged $414414.1 across 3 years, with a median of -$20165.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash surged 12205.4% — and 2025, when it plunged 12767.82%.
- Jupiter Neurosciences' Change in Cash stood at -$31137.0 in 2023, then soared by 12205.4% to $3.8 million in 2024, then dropped by 18.67% to $3.1 million in 2025.
- Business Quant data shows JUNS's Change in Cash at $3.1 million in Q4 2025, -$1.2 million in Q3 2025, and -$828222.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -828,222.00 |
| Mar 31, 2025 | -1.06 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | -14,598.00 |
| Jun 30, 2024 | 6,538.00 |
| Mar 31, 2024 | -20,165.00 |
| Dec 31, 2023 | -31,137.00 |